Market Cap: $10.18B
Market Cap: $10.18B
Open
$235.50
Prev. Close
$173.00
High
$238.44
Low
$234.94
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure.
DaVita Inc. trades on the New York Stock Exchange under the ticker DVA, priced in USD.
DaVita Inc. has a market capitalisation of $10.18B, based on its latest share price.
DVA trades at 13.29 times its trailing 12-month earnings.
Over the past 52 weeks DVA has traded between $101.00 and $247.49.
No. DaVita Inc. does not currently pay a dividend.
Profitable, with a net margin of 6.5% over the last 12 months.
The analyst consensus rating for DVA is Hold. Analysts' average 12-month price target of $219.60 implies 36% upside.
Javier J. Rodriguez is the CEO of DaVita Inc., which is headquartered in Denver.
Generated automatically from reported financial data. General information only, not financial advice.

DaVita Inc. ( DVA ) is navigating a challenging yet transformative landscape in kidney care, focusing on innovative care models and strategic partnerships to bolster its market position. As the compan…

DaVita Inc. ( DVA ) is drawing attention as the latest developments come into focus. DaVita Inc. (DVA) is fundamentally transforming the landscape of kidney care through innovative treatment models an…

DaVita Inc. ( DVA ) is making significant strides in the realm of kidney care, focusing on enhancing patient outcomes through various innovative initiatives and partnerships. With its Integrated Kidne…

DaVita is advancing its digital health narrative through a significant collaboration with eHealth Exchange, focusing on enhancing secure patient-access capabilities crucial for managing chronic kidney…